Hansoo Kim Clinical Oncology Society of Australia Annual Scientific Meeting 2022

Abstracts this author is presenting:

• Cost-benefit of pre-treatment dihydropyrimidine dehydrogenase genotyping to individualise fluoropyrimidine-based chemotherapy in a contemporary Australian setting. — Poster session 2